Otoimmün Hastalıklar ve Baş Ağrısı
Özet
Çocuk ve ergenlerde sıkça görülen baş ağrıları genellikle primer olsa da, vaskülitler, SLE, MS ve çeşitli romatolojik hastalıklar gibi otoimmün süreçler vasküler veya parankimal tutulumlarla sekonder baş ağrılarına yol açabilmektedir. Şimşekvari başlangıç, uykudan uyandırma veya sistemik bulguların eşlik etmesi gibi "alarm işaretleri", bu ciddi tabloların primer baş ağrılarından ayırt edilmesinde hayati öneme sahiptir. Tanıda detaylı öykü ve fizik muayenenin yanı sıra spesifik otoantikor testleri ve nörogörüntüleme yöntemleri kullanılmalı, altta yatan sistemik bozukluklar titizlikle araştırılmalıdır. Baş ağrısı, otoimmün hastalıklarda bazen ilk klinik belirti bazen de tromboz veya infarkt gibi ciddi komplikasyonların habercisi olabileceğinden, vakalar sistematik bir yaklaşımla ele alınmalıdır.
While headaches in children and adolescents are predominantly primary, autoimmune and rheumatological conditions—including vasculitis, SLE, and MS—often induce secondary headaches through vascular involvement, inflammation, or treatment side effects. Identifying "alarm signs" such as sudden onset, nocturnal occurrence, or association with systemic symptoms is crucial for differentiating these potentially serious pathologies from primary headache disorders. Effective diagnosis relies on a comprehensive history, thorough physical examination, specific autoantibody testing, and neuroimaging to investigate underlying systemic involvement. Since headaches can manifest as either the initial sign or an indicator of severe complications like thrombosis in autoimmune diseases, systematic evaluation of all patients is essential.
Referanslar
Dao JM, Qubty W. Headache Diagnosis in Children and Adolescents. Curr Pain Headache Rep. 2018 Feb 23;22(3):17. Dao JM, Qubty W. Headache Diagnosis in Children and Adolescents. Curr Pain Headache Rep. 2018 Feb 23;22(3):17.
Rho YI, Chung HJ, Lee KH, et al. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache. 2012 Apr;52(4):592-9.
Poyrazoğlu HG, Kumandas S, Canpolat M, Gümüs H, Elmali F, Kara A, et al. The prevalence of migraine and tension-type headache among schoolchildren in Kayseri, Turkey: an evaluation of sensitivity and specificity using multivariate analysis. J Child Neurol. 2015;30(7):889–95.
Foiadelli T, Piccorossi A, Sacchi L, De Amici M, Tucci M, Brambilla I, et al. Clinical characteristics of headache in Italian adolescents aged 11-16 years: a cross-sectional questionnaire school-based study. Ital J Pediatr. 2018;44(1):44.
Fontaine D, Almairac F, Santucci S, Fernandez C, Dallel R, Pallud J, Lanteri-Minet M. Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies. Brain. 2018 Apr 1;141(4):1040-1048.
Esparham AE, Dilts JJ. Integrative Management of Pediatric Primary Headaches. Pediatr Ann. 2019 Jun 1;48(6):e231-e235.
Lopez JI, Holdridge A, Chalela J. Headache and vasculitis. Curr Pain Headache Rep. 2013 Mar;17(3):320.
Silvestri E, Scalera A, Emmi G, Squatrito D, Ciucciarelli L, Cenci C, Tamburini C, Emmi L, Di Minno G, Prisco D. Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? Semin Thromb Hemost. 2016 Sep;42(6):650-61.
La Mantia L, Prone V. Headache in multiple sclerosis and autoimmune disorders. Neurol Sci. 2015 May;36 Suppl 1:75-8.
Puéchal X. Granulomatosis with polyangiitis (Wegener's). Joint Bone Spine. 2020 Dec;87(6):572-578.
Wolfs JF, Arts MP, Peul WC. Juvenile chronic arthritis and the craniovertebral junction in the paediatric patient: review of the literature and management considerations. Adv Tech Stand Neurosurg. 2014;41:143-56.
Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, Delain JC, Viallard JF. Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence. Autoimmun Rev. 2016 Jan;15(1):71-81.
John S, Hajj-Ali RA. Headache in autoimmune diseases. Headache. 2014 Mar;54(3):572-82.
Salvarani C, Brown RD Jr, Calamia KT, et al. Primary central nervous system vasculitis: Analysis of 101 patients. Ann Neurol.2007;62:442-451.
Takeshita Y. [Primary Central Nervous System Vasculitis]. Brain Nerve. 2021 May;73(5):511-515. Japanese.
Bond KM, Nasr D, Lehman V, Lanzino G, Cloft HJ, Brinjikji W. Intracranial and Extracranial Neurovascular Manifestations of Takayasu Arteritis. AJNR Am J Neuroradiol. 2017 Apr;38(4):766-772.
Mollan SP, Paemeleire K, Versijpt J, Luqmani R, Sinclair AJ. European Headache Federation recommendations for neurologists managing giant cell arteritis. J Headache Pain. 2020 Mar 17;21(1):28. doi: 10.1186/s10194-020-01093-7.
Zenone T, Knefati Y, Sabatier JC. Polyarteritis nodosa presenting with jaw claudication and headache. Joint Bone Spine. 2007 May;74(3):301-2. doi: 10.1016/j.jbspin.2006.09.011.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turk J Pediatr. 2020;62(1):1-9.
Rossi M, Siani P, Grossi A, Carannante N, Di Caprio G, Borrelli B, Sbrana F, Di Martino F, Sarno M, Tascini C. Aseptic meningitis as onset of Kawasaki disease. Minerva Pediatr. 2020 Apr;72(2):135-137.
Peng A, Yang X, Wu W, Xiao Z, Xie D, Ge S. Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature. Eur Arch Otorhinolaryngol. 2018 Dec;275(12):2915-2923.
Thompson B, Burns A. Subarachnoid hemorrhages in vasculitis. Am J Kidney Dis. 2003 Sep;42(3):582-5.
Borhani-Haghighi A, Kardeh B, Banerjee S, Yadollahikhales G, Safari A, Sahraian MA, Shapiro L. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment. Mult Scler Relat Disord. 2019 Dec 23;39:101906.
Azami A, Maleki N, Kalantar Hormozi M, Tavosi Z. Interstitial Keratitis, Vertigo, and Vasculitis: Typical Cogan's Syndrome. Case Rep Med. 2014;2014:830831.
Cavestro C, Ferrero M. Migraine in Systemic Autoimmune Diseases. Endocr Metab Immune Disord DrugTargets. 2018 Feb 13;18(2):124-134.
Tanaka Y. [Neuropsychiatric Systemic Lupus Erythematosus]. Brain Nerve. 2019 May;71(5):445 458. Japanese.
Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, de Souza AWS, Andrade D. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018 Aug;27(9):1404-1414.
Elhai M, Wipff J, Bazeli R, Freire V, Feydy A, Drapé JL, Quartier P, Kahan A, Job-Deslandre C. Radiological cervical spine involvement in young adults with polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford). 2013 Feb;52(2):267-75.
Takeuchi Y, Murahashi S, Hara Y, Ueda M. Possible Cerebral Vasculitis in a Case with Rheumatoid Arthritis. Intern Med. 2021 Mar 15;60(6):935-940.
Margaretten M. Neurologic Manifestations of Primary Sjögren Syndrome. Rheum Dis Clin North Am. 2017 Nov;43(4):519-529.
Pirau L, Lui F. Neurosarcoidosis. 2021 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 30521189.
Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016 Nov 15;16(1):220.
Bathla G, Abdel-Wahed L, Agarwal A, Cho TA, Gupta S, Jones KA, Priya S, Soni N, Wasserman BA. Vascular Involvement in Neurosarcoidosis: Early Experiences From Intracranial Vessel Wall Imaging. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 4;8(6):e1063.
Gebhardt M, Kropp P, Hoffmann F, Zettl UK. Kopfschmerzen bei Multipler Sklerose [Headache in multiple sclerosis]. Nervenarzt. 2020 Oct;91(10):926-935. German.
Seixas D, Foley P, Palace J, Lima D, Ramos I, Tracey I. Pain in multiple sclerosis: a systematic review of neuroimaging studies. Neuroimage Clin. 2014 Jul 5;5:322-31.
Ashrafi MR, Amirkashani D, Hirbod-Mobarakeh A, Yaghmaei B, Tavassoli A, Manafi F, Rezaei N. Acute disseminated encephalomyelitis mimicking acute meningoencephalitis. Acta Clin Croat. 2013 Dec;52(4):523-8.
Farmakidis C, Inan S, Milstein M, Herskovitz S. Headache and Pain in Guillain-Barré Syndrome. Curr Pain Headache Rep. 2015 Aug;19(8):40.
